The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1217
ISSUE1217
September 12, 2005
Tigecycline (Tygacil)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Tigecycline (Tygacil)
September 12, 2005 (Issue: 1217)
Tigecycline (Tygacil - Wyeth), a derivative of minocycline, is a new intravenous (IV) antibiotic approved for treatment of complicated intra-abdominal and skin and skin-structure infections.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.